Signaturefd, LLC Pro Qr Therapeutics N.V. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.9 - $8.39 $1,824 - $17,006	-2,027 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$6.58 - $8.44 $348 - $447	53 Added 2.68%	2,027 $16,000
Q3 2021 Oct 28, 2021	BUY	$5.16 - $8.47 $8,689 - $14,263	1,684 Added 580.69%	1,974 $17,000
Q2 2021 Jul 26, 2021	BUY	$5.75 - $7.59 $1,667 - $2,201	290 New	290 $2,000
Q4 2020 Feb 11, 2021	SELL	$3.58 - $4.85 $1,542 - $2,090	-431 Closed	0 $0
Q2 2020 Jul 30, 2020	SELL	$4.5 - $6.53 $67 - $97	-15 Reduced 3.36%	431 $3,000
Q1 2020 Apr 23, 2020	BUY	$5.25 - $9.9 $2,341 - $4,415	446 New	446 $2,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $157M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.